...
首页> 外文期刊>Aviation, space, and environmental medicine. >First-generation H1 antihistamines found in pilot fatalities of civil aviation accidents, 1990-2005.
【24h】

First-generation H1 antihistamines found in pilot fatalities of civil aviation accidents, 1990-2005.

机译:1990-2005年,在民航事故飞行员死亡中发现的第一代H1抗组胺药。

获取原文
获取原文并翻译 | 示例
           

摘要

INTRODUCTION: First-generation H1-receptor antagonists are popularly used for alleviating allergy and cold symptoms, but these antihistaminics cause drowsiness and sedation. Such side effects could impair performance and, thus, could be the cause or a factor in accidents. Therefore, the prevalence of these antagonists was evaluated in aviation accident pilot fatalities. METHODS: The Civil Aerospace Medical Institute's (CAMI's) Toxicology Database was examined for the presence of the first-generation antihistamines in pilot fatalities of civil aircraft accidents that occurred during a 16-yr (1990-2005) period. RESULTS: Of 5383 fatal aviation accidents from which CAMI received specimens, there were 338 accidents wherein pilot fatalities (cases) were found to contain brompheniramine, chlorpheniramine, diphenhydramine, doxylamine, pheniramine, phenyltoloxamine, promethazine, and triprolidine. Of the 338 accidents, 304 were general aviation accidents, and 175 of the 338 pilots held private pilot airman certificates. Antihistamines were detected alone in 103 fatalities (1 antihistamine in 94 and 2 antihistamines in 9), while other drug(s) and/or ethanol were also present in an additional 235 fatalities. The antihistamines were found in approximately 4 and 11% of the fatalities/accidents in 1990 and in 2004, respectively. The use of antihistamine(s) was determined by the National Transportation Safety Board to be the cause of 13 and a factor in 50 of the 338 accidents. CONCLUSIONS: There was an overall increasing trend in the use of antihistamines by aviators during the 16-yr span. Blood levels of the antihistaminics were in the sub-therapeutic to toxic range. Findings from this study will be useful in investigating future accidents involving antihistamines.
机译:简介:第一代H1受体拮抗剂普遍用于缓解过敏和感冒症状,但是这些抗组胺药会引起嗜睡和镇静作用。这种副作用可能会损害性能,因此可能是事故的原因或因素。因此,在航空事故飞行员死亡中评估了这些拮抗剂的患病率。方法:检查了在16年(1990年至2005年)期间发生的民用航空器驾驶员死亡事故中第一代抗组胺药的存在,分析了民航医学研究所(CAMI)的毒理学数据库。结果:在CAMI收到标本的5383例致命航空事故中,有338例飞行员死亡(病例)被发现含有溴苯那敏,氯苯那敏,苯海拉明,多西拉敏,苯那拉明,苯基托洛沙明,异丙嗪和三苯吡啶。在338起事故中,有304起是通用航空事故,在338名飞行员中有175名持有私人飞行员执照。在103例死亡中仅检测到抗组胺药(94例中1种抗组胺药和9例中2种抗组胺药),另外235例死亡中还存在其他药物和/或乙醇。 1990年和2004年分别在约4%和11%的死亡/事故中发现了抗组胺药。国家运输安全委员会确定使用抗组胺剂是13例的原因,也是338例事故中的50例。结论:在16年的时间里,飞行员使用抗组胺药的总体趋势有所增加。抗组胺药的血液水平处于亚治疗至毒性范围内。这项研究的结果将有助于调查涉及抗组胺药的未来事故。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号